Retinol and Retinol Binding Protein 4 Levels and COVID-19: a Mendelian Randomization Study

Overview

Journal BMC Pulm Med

Publisher Biomed Central

Specialty Pulmonary Medicine

Date 2024 Apr 26

PMID 38671384

Authors

Haixia Wang

Zhiyun Zhang

Li Xie

Kongli Lu

Shuyi Zhang

Shunpeng Xing

Affiliations

Soon will be listed here.

Abstract

Background: The Corona Virus Disease 2019 (COVID-19) pandemic has struck globally. Whether the related proteins of retinoic acid (RA) signaling pathway are causally associated with the risk of COVID-19 remains unestablished. We conducted a two-sample Mendelian randomization (MR) study to assess the associations of retinol, retinol binding protein 4 (RBP4), retinol dehydrogenase 16 (RDH16) and cellular retinoic acid binding protein 1 (CRABP1) with COVID-19 in European population.

Methods: The outcome utilized the summary statistics of COVID-19 from the COVID-19 Host Genetics Initiative. The exposure data were obtained from public genome wide association study (GWAS) database. We extracted SNPs from exposure data and outcome data. The inverse variance weighted (IVW), MR-Egger and Wald ratio methods were employed to assess the causal relationship between exposure and outcome. Sensitivity analyses were performed to ensure the validity of the results.

Results: The MR estimates showed that retinol was associated with lower COVID-19 susceptibility using IVW (OR: 0.69, 95% CI: 0.53-0.90, P: 0.0065), whereas the associations between retinol and COVID-19 hospitalization or severity were not significant. RBP4 was associated with lower COVID-19 susceptibility using the Wald ratio (OR: 0.83, 95% CI: 0.72-0.95, P: 0.0072). IVW analysis showed RDH16 was associated with increased COVID-19 hospitalization (OR: 1.10, 95% CI: 1.01-1.18, P: 0.0199). CRABP1 was association with lower COVID-19 susceptibility (OR: 0.95, 95% CI: 0.91-0.99, P: 0.0290) using the IVW.

Conclusions: We found evidence of possible causal association of retinol, RBP4, RDH16 and CRABP1 with the susceptibility, hospitalization and severity of COVID-19. Our study defines that retinol is significantly associated with lower COVID-19 susceptibility, which provides a reference for the prevention of COVID-19 with vitamin A supplementation.

References

Sarohan A . COVID-19: Endogenous Retinoic Acid Theory and Retinoic Acid Depletion Syndrome. Med Hypotheses. 2020; 144:110250. PMC: 7481114. DOI: 10.1016/j.mehy.2020.110250. View

Kawai T, Akira S . Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci. 2008; 1143:1-20. DOI: 10.1196/annals.1443.020. View

Sarohan A, Kizil M, Inkaya A, Mahmud S, Akram M, Cen O . A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder. Cell Signal. 2021; 87:110121. PMC: 8380544. DOI: 10.1016/j.cellsig.2021.110121. View

Kamat M, Blackshaw J, Young R, Surendran P, Burgess S, Danesh J . PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019; 35(22):4851-4853. PMC: 6853652. DOI: 10.1093/bioinformatics/btz469. View

Szymanski L, Skopek R, Palusinska M, Schenk T, Stengel S, Lewicki S . Retinoic Acid and Its Derivatives in Skin. Cells. 2020; 9(12). PMC: 7764495. DOI: 10.3390/cells9122660. View

Sanderson E, Spiller W, Bowden J . Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization. Stat Med. 2021; 40(25):5434-5452. PMC: 9479726. DOI: 10.1002/sim.9133. View

Ghyselinck N, Duester G . Retinoic acid signaling pathways. Development. 2019; 146(13). PMC: 6633611. DOI: 10.1242/dev.167502. View

Nhieu J, Milbauer L, Lerdall T, Najjar F, Wei C, Ishida R . Targeting Cellular Retinoic Acid Binding Protein 1 with Retinoic Acid-like Compounds to Mitigate Motor Neuron Degeneration. Int J Mol Sci. 2023; 24(5). PMC: 10002585. DOI: 10.3390/ijms24054980. View

Vollenberg R, Tepasse P, Fobker M, Husing-Kabar A . Significantly Reduced Retinol Binding Protein 4 (RBP4) Levels in Critically Ill COVID-19 Patients. Nutrients. 2022; 14(10). PMC: 9147114. DOI: 10.3390/nu14102007. View

10.

Stephensen C, Lietz G . Vitamin A in resistance to and recovery from infection: relevance to SARS-CoV2. Br J Nutr. 2021; 126(11):1663-1672. PMC: 7884725. DOI: 10.1017/S0007114521000246. View

11.

Burgess S, Butterworth A, Thompson S . Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013; 37(7):658-65. PMC: 4377079. DOI: 10.1002/gepi.21758. View

12.

Das B, Thapa P, Karki R, Das S, Mahapatra S, Liu T . Retinoic acid signaling pathways in development and diseases. Bioorg Med Chem. 2014; 22(2):673-83. PMC: 4447240. DOI: 10.1016/j.bmc.2013.11.025. View

13.

Allenby G, Bocquel M, Saunders M, Kazmer S, Speck J, Rosenberger M . Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci U S A. 1993; 90(1):30-4. PMC: 45593. DOI: 10.1073/pnas.90.1.30. View

14.

Shoemark D, Colenso C, Toelzer C, Gupta K, Sessions R, Davidson A . Molecular Simulations suggest Vitamins, Retinoids and Steroids as Ligands of the Free Fatty Acid Pocket of the SARS-CoV-2 Spike Protein*. Angew Chem Int Ed Engl. 2021; 60(13):7098-7110. PMC: 8013358. DOI: 10.1002/anie.202015639. View

15.

Tepasse P, Vollenberg R, Fobker M, Kabar I, Schmidt H, Meier J . Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis. Nutrients. 2021; 13(7). PMC: 8308355. DOI: 10.3390/nu13072173. View

16.

Sun B, Maranville J, Peters J, Stacey D, Staley J, Blackshaw J . Genomic atlas of the human plasma proteome. Nature. 2018; 558(7708):73-79. PMC: 6697541. DOI: 10.1038/s41586-018-0175-2. View

17.

Burgess S, Thompson S . Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017; 32(5):377-389. PMC: 5506233. DOI: 10.1007/s10654-017-0255-x. View

18.

Majumder J, Minko T . Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19. AAPS J. 2021; 23(1):14. PMC: 7784226. DOI: 10.1208/s12248-020-00532-2. View

19.

Skrivankova V, Richmond R, Woolf B, Davies N, Swanson S, VanderWeele T . Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ. 2021; 375:n2233. PMC: 8546498. DOI: 10.1136/bmj.n2233. View

20.

Chow K, Gale Jr M, Loo Y . RIG-I and Other RNA Sensors in Antiviral Immunity. Annu Rev Immunol. 2018; 36:667-694. DOI: 10.1146/annurev-immunol-042617-053309. View